ASL Financial’s AbbVie ABBV Stock Holding History

ASL Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$653K	Hold	2,593	–	–	0.46%	45
2026 Q1	$564K	Hold	2,593	–	–	0.45%	45
2025 Q4	$592K	Buy	+2,593	New	+$591K	0.47%	42

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

ASL Financial's ABBV Position: Q2 2026 in Review

ASL Financial held its AbbVie (ABBV) position steady in Q2 2026 at 2,593 shares worth $653K. The position accounts for 0.46% of the portfolio, ranked #45.

ASL Financial first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

ASL Financial held 2,593 shares of AbbVie worth $653K as of Q2 2026.
ASL Financial left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.46% of ASL Financial's portfolio in Q2 2026, its #45 holding.
ASL Financial first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on ASL Financial's 13F filing for Q2 2026, filed 21 Jul 2026.